What Cantabria Labs Difa Cooper does

Cantabria Labs Difa Cooper (legal name: Difa Cooper SpA) is an Italian dermatology company founded in 1959 and headquartered in Caronno Pertusella (Varese), operating as a wholly owned subsidiary (Socio Unico) of the Spanish group Industrial Farmacéutica Cantabria S.A. The company develops, manufactures, and distributes a broad portfolio of dermatological products organised into four categories: drugs (farmaci), cosmetics (cosmetici), food supplements (integratori alimentari), and medical devices (dispositivi medici). Two flagship sub-brands anchor the portfolio — Heliocare for photoprotection built on the proprietary FERNBLOCK® (Polypodium leucotomos) extract, and Endocare for anti-aging skincare built on SCA® and RETINSPHERE® technologies — alongside condition-specific lines addressing acne (Biretix), rosacea (Eutrosis), hair loss (GFm, Adenosil, Tricostimolin-A), scar treatment (Vicutix Scar), and supportive oncology skincare (Onco Quality Life).

Underpinning the portfolio are more than 20 proprietary, trademarked technologies spanning active ingredients, delivery systems (e.g., Glicosfere, Melatosphere, Polyvinyl A), and biotech-derived peptides (MIMICKING GROWTH FACTORS®), supported by over 80 scientific studies, with FERNBLOCK® positioned as a full-spectrum (UVB, UVA, visible, IR) photoprotectant. Distribution is exclusively through the Italian pharmacy and parapharmacy channel, supported by what the company describes as the broadest commercial medical information network in Italian dermatology — a field force that engages daily with physicians, pharmacists, and patients — and by an online pharmacy locator. The revenue model is a one-time sale across each product category, with no disclosed subscription, SaaS, or licensing monetisation. Commercial activity is complemented by a CSR partnership with LILT (Lega Italiana per la Lotta contro i Tumori) for free mole screening using Heliocare products. The Italian entity has a share capital of €750,000 and is subject to direction and coordination by its Spanish parent.

Name

Cantabria Labs Difa Cooper

Legal name

Difa Cooper SpA

Website

https://cantabrialabsdifacooper.it

Company type

Private

Founded year

1959

Operating status

Operating

Short description

Cantabria Labs Difa Cooper is an Italian dermatology company, founded in 1959 and wholly owned by Spain's Industrial Farmacéutica Cantabria, that develops and distributes drugs, cosmetics, food supplements, and medical devices exclusively through Italian pharmacies, anchored by the Heliocare and Endocare sub-brands.

Ownership category

akta.pro rank

Product category

Dermatological Products

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Dermatology Specialty Pharmaceuticals (HLAIACAL)

akta.pro secondary industries

Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Vitamins & Minerals (Single Nutrients) (CRADAGAB)

Keywords

• Dermatological products
• Skincare cosmetics
• Pharmaceutical drugs
• Food supplements
• Medical devices

Headquarters

HQ city

Caronno Pertusella

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Cosmetics (Cosmetici): Topical skincare products including creams, gels, lotions, masks, and shampoos for face, body, hair, and nails. Sold exclusively through pharmacies and parapharmacies.
2. Drugs/Medicines (Farmaci): Prescription and over-the-counter pharmaceutical products for dermatological conditions. Includes acne treatments, hair loss treatments, and other therapeutic products.
3. Food Supplements (Integratori alimentari): Dietary supplements in capsule, tablet, and stick formats for skin, hair, and nail health. Contains natural extracts, vitamins, minerals, and amino acids.
4. Medical Devices (Dispositivi medici): Medical devices for scar treatment, wound healing, skin barrier protection, and other dermatological applications. Includes products like VICUTIX SCAR, RETINCARE, and ECOCEL.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Cantabria Labs Difa Cooper develops, manufactures and distributes a dermatology-focused portfolio comprising drugs (farmaci), cosmetics (cosmetici), food supplements (integratori alimentari) and medical devices (dispositivi medici). Flagship ranges include the HELIOCARE photoprotection sub-brand built around the proprietary Fernblock technology (Polypodium leucotomos extract) and the ENDOCARE anti-aging sub-brand built around SCA growth factors and Retinsphere technology. All products are sold exclusively through Italian pharmacies and parapharmacies, marketed through a national medical information network that engages daily with dermatologists, pharmacists and patients.

Product overview

Cantabria Labs Difa Cooper is a dermatological company operating since 1959, offering a comprehensive portfolio of topical products organized into four main categories: Cosmetics (cosmetici), Drugs (farmaci), Food Supplements (integratori alimentari), and Medical Devices (dispositivi medici). Key product sub-brands include HELIOCARE (photoprotection with SPF and Fernblock technology) and ENDOCARE (anti-aging with retinsphere technology). The product range addresses various skin concerns including acne, rosacea, psoriasis, dermatitis, actinic damage, hair loss, and nail problems. Distribution is exclusively through pharmacies and parapharmacies in Italy. The company employs proprietary technologies including Fernblock, Retinsphere, MIMICKING GROWTH FACTORS, NUCLEDIL, 1-3 ATODINA, SCA, and others developed through decades of dermatological research.

Differentiator

Problem solved

Functional benefit

Brands

• Heliocare: Photoprotection product line featuring Fernblock technology, available as topical sunscreens and oral supplements.
• Endocare

Products and services

• HELIOCARE Sub-brand of topical sunscreens (SPF 50+, SPF 100+) and oral photoprotection supplements built around the proprietary FERNBLOCK® Polypodium leucotomos extract, providing full-spectrum protection against UVB, UVA, visible light and infrared radiation. Sold through Italian pharmacies and parapharmacies; marketed to dermatologists, pharmacists and end consumers concerned with sun damage, photoaging, oxidative stress and skin cancer prevention.
• ENDOCARE Anti-aging skincare line leveraging proprietary RETINSPHERE® (retinoid-based) and SCA® (growth factor) technologies for skin regeneration, renewal and wrinkle reduction. Sold in Italian pharmacies for adult consumers seeking clinically backed anti-aging solutions.
• GFm Densactive Topical gel cosmetic indicated for all forms of hair loss, using MIMICKING GROWTH FACTORS® technology to help prolong the anagen (growth) phase. Sold through Italian pharmacies.
• GFm Lozione Topical solution with a high concentration of the GFM complex of polypeptides, indicated as coadjuvant in all forms of hair loss. Pharmacy-channel cosmetic.
• ADENOSIL Shampoo Delicate anti-hair-loss shampoo suitable for all hair types and daily use, featuring 1-3 ATODINA® technology (Adenosine, Ornithine, Taurine complex) to normalize the scalp. Pharmacy cosmetic.
• ADENOSIL Maschera Restructuring mask for dry, damaged hair, with 1-3 ATODINA® technology to help counteract hair loss and increase hair diameter. Sold in Italian pharmacies.
• TRICOSTIMOLIN-A Adjuvant cosmetic treatment for physiological hair regrowth combining oligotherapy trace elements to support hair and scalp trophism. Pharmacy cosmetic.
• NIPON E Ultra Food supplement combining flaxseed oil, evening primrose oil and zinc to support physiological skin trophism and the maintenance of normal hair. Distributed through Italian pharmacies and parapharmacies.
• DIECI PLUS Food supplement of amino acids, zinc, ornithine and taurine supporting the maintenance of normal hair, nails and skin. Distributed through Italian pharmacies.
• HELIOCARE 360° Gel Cream 100+ High-protection facial sunscreen (SPF 100+) featuring FERNBLOCK® technology for advanced dermatological photoprotection. Pharmacy cosmetic.
• HELIOCARE 360° Capsule Oral food-supplement capsules featuring FERNBLOCK® technology for systemic photoprotection, complementing topical sunscreen use. Pharmacy food supplement.
• HELIOCARE 360° A-R Emulsion SPF 50+ SPF 50+ sunscreen emulsion for sensitive skin prone to rosacea or redness, combining high photoprotection with anti-redness properties. Pharmacy cosmetic.
• EUTROSIS Cosmetic line for rosacea- and redness-prone skin conditions, leveraging proprietary NUCLEDIL® and related actives. Distributed through Italian pharmacies.
• BIRETIX Cosmetic line for acne-prone skin (also referenced as a food supplement for skin support). Sold through Italian pharmacies.
• P.O.L. Product line built on patented P.O.L.® technology for skin-barrier repair and hydration, offered both as a cosmetic and as a medical device in the corresponding category page.
• ECOCEL Unghie (nails) Nail treatment product available in cosmetic and medical device formulations. Sold in Italian pharmacies.
• AMPCARE Product offered both as a food supplement and as a medical device for specific dermatological applications. Pharmacy channel.
• Onco Quality Life Cosmetic line for oncology patients to support skin care during and after cancer treatments. Distributed through Italian pharmacies.
• VICUTIX SCAR Medical device for scar treatment and reduction. Distributed exclusively through Italian pharmacies.
• RETINCARE Medical device for specific dermatological applications, complementing the RETINSPHERE®-based anti-aging range. Pharmacy channel.
• ACTIXICAM Medical device for dermatological applications. Sold through Italian pharmacies.
• MASK Dermatological medical device product, sold exclusively through Italian pharmacies.
• MASKRYM Dermatological medical device product, sold exclusively through Italian pharmacies.
• CAREDIESSE (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.
• CAREFINAST (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.
• CAREXIDIL (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category, used in hair-related indications. Distributed through Italian pharmacies.
• FLUTICREM (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.
• IMUNOCARE (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.
• ISOTRETINOINA (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category, used in acne indications. Distributed through Italian pharmacies.
• NEBIOTIN (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category, used in hair/nail indications. Distributed through Italian pharmacies.
• TRANS-VER-SAL (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.
• VEREGEN (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.
• ZINDACLIN (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category, used in acne indications. Distributed through Italian pharmacies.
• ZORIAS (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.
• VELOS (farmaco) Dermatological pharmaceutical product within the drugs (farmaci) category. Distributed through Italian pharmacies.
• AGA PLUS (integratore alimentare) Food supplement supporting hair well-being in androgenetic alopecia and related conditions, distributed through Italian pharmacies.
• NIPON E (integratore alimentare) Food supplement variant of the NIPON E line for skin and hair nutrition, sold through Italian pharmacies.
• DIECI PLUS (integratore alimentare) Food supplement supporting hair, skin and nails, sold through Italian pharmacies.

Quantifiable outcome

• More than 80 scientific studies supporting Fernblock technology efficacy
• +1 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature23 records

Partnerships

One partnership is on record.

• LILT (Lega Italiana per la Lotta contro i Tumori)minorStrategic or Co-development PartnerPartnership for health awareness initiatives including free mole screening programs. Difa Cooper provides Heliocare sunscreen products to support LILT's skin cancer prevention campaigns. This represents a corporate social responsibility partnership focused on dermatological health education and prevention.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Bionike: Italian dermo-cosmetics company targeting sensitive, allergic, and reactive skin with pharmacy-channel distribution; direct domestic competitor with overlapping customer segments (special populations, sensitive skin).
• Rilastil (Istituto Ganassini): Italian dermo-cosmetics brand with a strong pharmacy-channel presence across skincare, sun care, and body care—directly comparable in go-to-market (Italian pharmacy exclusive distribution) and dermatology positioning.
• Giuliani: Italian pharmaceutical company with a dedicated dermatology, hair-care, and gut-skin portfolio distributed through pharmacy channels—comparable Italian-market dermatology peer.
• Galderma: Global dermatology company with both Rx and skincare/consumer franchises serving dermatologists and patients; comparable in prescription dermatology pipeline and OTC/consumer dermatology assets.
• Bioderma (NAOS): NAOS's dermo-cosmetics brand focused on biology-driven dermatological skincare in pharmacy channels—closely comparable in positioning around dermatology-first formulations and pharmacy distribution.
• ISDIN: Spanish-based dermo-cosmetics leader with a portfolio anchored in photoprotection and dermatological skincare, sold through pharmacy channels with overlapping Italian and European distribution—closely aligned in business model and product mix.
• Almirall: Spanish dermatology-focused pharmaceutical company with Rx and OTC medical-dermatology products across Europe; comparable as a Southern-European dermatology specialty pharma with a similar physician-driven model.

Broad incumbents

• Eucerin (Beiersdorf): Beiersdorf's medical-skincare brand with a portfolio spanning acne, atopic skin, sun protection, and anti-aging—directly overlapping therapeutic dermatology categories and pharmacy distribution.
• Avène (Pierre Fabre Dermatologie): Pierre Fabre's dermo-cosmetics brand centered on thermal-spring water and sensitive-skin dermatology; broadly comparable in pharmacy-channel, dermatologist-recommended dermatology positioning.
• La Roche-Posay (L'Oréal Dermatological Beauty): L'Oréal's global dermatological beauty division and the leading pharmacy-channel dermo-cosmetics brand; competes across sensitive skin, acne, and photoprotection—the same core verticals where Cantabria Labs Difa Cooper operates.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/difa.cooper
• LinkedInlinkedin.com/company/difa-cooper
• Instagraminstagram.com/difacooper

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cantabria Labs Difa Cooper